Xender Biopharma & Research LLP
About Xender Biopharma & Research LLP
Data last updated:
Xender Biopharma & Research LLP is a limited liability partnership (LLP) based in Surat, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 March 2016 and has been in existence for over 10 years.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAF-8957.
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Ramesh Narsinhbhai Patel and Chiragkumar Nagarbhai Patel.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at 2nd Floor Shop – S/8 Sy No – 153/6 Silver Point Opp. Vidhya Bharti School Bhatar Road, Surat, Gujarat, India – 395007.
As per MCA filings, the LLP has open charges of ₹85.8 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address2nd Floor Shop – S/8 Sy No – 153/6 Silver Point Opp. Vidhya Bharti School Bhatar Road, Surat, Gujarat, India – 395007
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Xender Biopharma & Research LLP FY 2025 filings available
Financial Statement Summary of Xender Biopharma & Research LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Xender Biopharma & Research LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Xender Biopharma & Research are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Xender Biopharma & Research LLP
Xender Biopharma & Research has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramesh Narsinhbhai Patel | Designated Partner | 10 Mar 2016 | 10 Years 7 Months | Current |
| Chiragkumar Nagarbhai Patel | Designated Partner | 10 Mar 2016 | 10 Years 7 Months | Current |
Charges & Borrowings of Xender Biopharma & Research LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 May 2022 | Icici Bank Limited | ₹85.8 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Xender Biopharma & Research LLP
Employment history and EPFO contributions of people linked to Xender Biopharma & Research.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Xender Biopharma & Research LLP
Xender Biopharma & Research LLP has 3 designated partner changes on record since 2016: 2 appointments and 1 cessation. The latest: Saurinkumar Rasiklal Patel ceased to be Partner on 09 Oct 2019.
Credit Ratings, Litigation & Regulatory Alerts for Xender Biopharma & Research LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Xender Biopharma & Research LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Xender Biopharma & Research LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Xender Biopharma & Research LLP
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Xender Biopharma & Research LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Xender Biopharma & Research LLP
Xender Biopharma & Research is an active limited liability partnership based in Surat, Gujarat, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 10 March 2016 (10+ years old) and is registered under LLPIN AAF-8957.
Xender Biopharma & Research has 2 current designated partners:
- Ramesh Narsinhbhai Patel - Designated Partner
- Chiragkumar Nagarbhai Patel - Designated Partner
The LLPIN (Limited Liability Partnership Identification Number) of Xender Biopharma & Research is AAF-8957. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Xender Biopharma & Research was incorporated on 10 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Saurinkumar Rasiklal Patel ceased to be Partner on 09 Oct 2019. Chiragkumar Nagarbhai Patel was appointed as Designated Partner on 10 Mar 2016. Ramesh Narsinhbhai Patel was appointed as Designated Partner on 10 Mar 2016.
The registered office of Xender Biopharma & Research is at 2nd Floor Shop – S8 Sy No – 1536 Silver Point Opp. Vidhya Bharti School Bhatar Road, Surat, Gujarat, India – 395007.
The total obligation of contribution is ₹1 Lakh.
Xender Biopharma & Research operates in the pharma industry, in the drug formulation and development segment.
Xender Biopharma & Research has open charges of ₹85.8 Lakh and no satisfied charges on record as per latest MCA filings.
Xender Biopharma & Research can be reached at its registered office: 2nd Floor Shop – S8 Sy No – 1536 Silver Point Opp. Vidhya Bharti School Bhatar Road, Surat, Gujarat, India – 395007.